V VERALOX THERAPEUTICS Trademark

Trademark Overview

On Thursday, May 19, 2022, a trademark application was filed for V VERALOX THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the V VERALOX THERAPEUTICS trademark a serial number of 97419165. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, December 11, 2023. This trademark is owned by Veralox Therapeutics Inc.. The V VERALOX THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, chemical and small molecule and biological preparations for use in treatment of blood disorders and diabetes; pharmaceutical and biological formulations for treatment of blood disorders and diabetes
v veralox therapeutics

General Information

Serial Number97419165
Word MarkV VERALOX THERAPEUTICS
Filing DateThursday, May 19, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, December 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements

Description of MarkThe mark consists of a hexagon with the letter "V" inscribed within, accompanied by the text "VERALOX THERAPEUTICS".
Goods and ServicesPharmaceutical products, namely, chemical and small molecule and biological preparations for use in treatment of blood disorders and diabetes; pharmaceutical and biological formulations for treatment of blood disorders and diabetes
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVeralox Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFrederick, MD 21703
Party NameVeralox Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFrederick, MD 21704

Trademark Events

Event DateEvent Description
Monday, February 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 12, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 12, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 12, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 12, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 11, 2023SOU EXTENSION 1 GRANTED
Monday, December 11, 2023SOU EXTENSION 1 FILED
Monday, December 11, 2023SOU TEAS EXTENSION RECEIVED
Monday, December 11, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 11, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 11, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 16, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, March 16, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 16, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, March 16, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 8, 2023ASSIGNED TO EXAMINER
Thursday, May 26, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, May 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 23, 2022NEW APPLICATION ENTERED

Related Keywords

therapeutics veralox treatment blood disorders diabetes pharmaceutical biological products formulations namely chemical